Related Experiment Video
Updated: Apr 25, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Adipocyte ALK7 links nutrient overload to catecholamine resistance in obesity
Tingqing Guo1, Patricia Marmol2, Annalena Moliner3
1Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden Department of Physiology, National University of Singapore, Singapore, Singapore.
Abstract:
Obesity is associated with blunted β-adrenoreceptor (β-AR)-mediated lipolysis and lipid oxidation in adipose tissue, but the mechanisms linking nutrient overload to catecholamine resistance are poorly understood. We report that targeted disruption of TGF-β superfamily receptor ALK7 alleviates diet-induced catecholamine resistance in adipose tissue, thereby reducing obesity in mice. Global and fat-specific Alk7 knock-out enhanced adipose β-AR expression, β-adrenergic signaling, mitochondrial biogenesis, lipid oxidation, and lipolysis under a high fat diet, leading to elevated energy expenditure, decreased fat mass, and resistance to diet-induced obesity. Conversely, activation of ALK7 reduced β-AR-mediated signaling and lipolysis cell-autonomously in both mouse and human adipocytes. Acute inhibition of ALK7 in adult mice by a chemical-genetic approach reduced diet-induced weight gain, fat accumulation, and adipocyte size, and enhanced adipocyte lipolysis and β-adrenergic signaling. We propose that ALK7 signaling contributes to diet-induced catecholamine resistance in adipose tissue, and suggest that ALK7 inhibitors may have therapeutic value in human obesity.
Insights
Targeted disruption of ALK7 alleviates diet-induced obesity by enhancing beta-adrenergic signaling in adipose tissue. This improves lipolysis and lipid oxidation, offering a potential therapeutic target for obesity.
Area of Science:
- Metabolism and Endocrinology
- Cell Biology
- Obesity Research
Background:
- Obesity is linked to reduced lipolysis and lipid oxidation in adipose tissue due to blunted beta-adrenoreceptor (β-AR) signaling.
- The precise mechanisms connecting nutrient overload to catecholamine resistance in obesity remain unclear.
Purpose of the Study:
- To investigate the role of TGF-β superfamily receptor ALK7 in diet-induced catecholamine resistance and obesity.
- To explore ALK7 as a potential therapeutic target for obesity.
Main Methods:
- Utilized global and fat-specific Alk7 knock-out mouse models.
- Administered high-fat diets to induce obesity.
- Employed chemical-genetic approaches for acute ALK7 inhibition in adult mice.
- Assessed β-AR expression, β-adrenergic signaling, lipolysis, lipid oxidation, and mitochondrial biogenesis in adipose tissue.
- Investigated ALK7 effects in both mouse and human adipocytes.
Main Results:
- Targeted disruption of ALK7 in mice reduced diet-induced obesity.
- Alk7 deficiency enhanced adipose β-AR expression, signaling, lipolysis, and lipid oxidation under high-fat diet conditions.
- Activation of ALK7 inhibited β-AR signaling and lipolysis in adipocytes.
- Acute ALK7 inhibition in adult mice decreased weight gain, fat accumulation, and adipocyte size while enhancing lipolysis and β-adrenergic signaling.
Conclusions:
- ALK7 signaling contributes to diet-induced catecholamine resistance in adipose tissue.
- Inhibition of ALK7 may represent a novel therapeutic strategy for managing human obesity.
More Related Videos
10:40Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro
Published on: December 5, 2025
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Related Concept Videos
Obesity
cAMP-dependent Protein Kinase Pathways
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
Regulation of Food Intake
GPCRs Regulate Adenylyl Cylase Activity
Cushing Syndrome II: Pathophysiology